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Abstract
Background—Isocyanates remain a leading cause of work-related asthma (WRA). Methods 
Two independent data systems were analyzed for the period 1993–2008: (1) State-based WRA 
case surveillance data on persons with isocyanate-induced WRA from four states, and (2) 
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Occupational Safety and Health Administration (OSHA) Integrated Management Information 
System (IMIS) isocyanate air sampling results.
Results—We identified 368 cases of isocyanate-induced WRA from 32 industries and 678 
OSHA isocyanate air samples with detectable levels from 31 industries. Seventeen industries were 
unique to one or the other dataset.
Conclusion—Isocyanate-induced WRA continues to occur in a wide variety of industries. Two 
data systems uncovered industries with isocyanate exposures and/or illness. Improved control 
measures and standards, including medical surveillance, are needed. More emphasis is needed on 
task-specific guidance, spill clean-up procedures, skin and respiratory protection, and targeted 
medical monitoring to mitigate the hazards of isocyanate use.
Keywords
work-related asthma; isocyanates; occupational health surveillance; occupational disease 
prevention
INTRODUCTION
The respiratory hazards of isocyanates were first reported in the 1950s and isocyanates were 
recognized as a cause of work-related asthma (WRA) by the end of that decade [Woodbury, 
1956; Hama, 1957; Walworth and Virchow, 1959; Elkins et al., 1962; Brugsch and Elkins, 
1963; Gandevia, 1963; Longley, 1964]. Today, isocyanates remain a leading cause of WRA 
in industrialized countries[Meredith et al., 2000; Bello et al., 2004; Redlich et al., 2006; 
Vandenplas 2011], inducing asthma in 1–30% of exposed workers [Wisnewski et al., 2006; 
Bello et al., 2007; Lockey et al., 2015]. WRA includes both new-onset asthma induced by 
exposure to irritants or sensitizers in the workplace and pre-existing asthma exacerbated by 
workplace exposure [Jajosky et al., 1999]. Exposure to isocyanates may occur through 
inhalation or dermal contact [Bello et al., 2007; Redlich and Herrick, 2008; Liu, 2009; 
Redlich, 2010]. In individuals who are sensitized to isocyanates, asthma attacks with 
immediate, delayed, or dual-onset symptoms may be triggered by exposures to 
concentrations of isocyanates well below occupational exposure limits [Wegman et al., 
1974; Banks et al., 1989; Lemiere et al., 2002]. The physiologic mechanism of how 
isocyanates cause asthma is not fully understood. Nevertheless, the lag between exposure 
and symptom onset along with the recurrence of asthma attacks from re-exposure to low 
concentrations are consistent with an immune-mediated model [Woodbury, 1956; 
Wisnewski and Jones, 2010].
Isocyanates are a group of highly reactive, low molecular weight compounds containing the 
functional group ─N═C═O, and are classified as aliphatic or aromatic [Bello et al., 2004]. 
Common forms include the aromatic methylene bisphenyl diisocyanate (MDI) and toluene 
diisocyanate (TDI); and the aliphatic hexamethlyene diisocyanate (HDI). Polyisocyanates 
are a mixture of diisocyanate monomers and other diisocyanate reaction products; pre-
polymers are created from the reaction of polyols with di- or polyisocyanates [Vandenplas et 
al., 1992; Redlich et al., 2006]. Both polyisocyanates and prepolymers have free isocyanate 
groups (─N═C═O), and can therefore undergo further reactions.
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Isocyanates are used in a number of products, including paints, coatings, polyurethane 
products, foams (rigid and flexible), adhesives, and sealants, across a variety of industries 
[Wisnewski et al., 2006]. The American Chemistry Council reported that 4,143 million 
pounds of isocyanate-containing polyurethane products were used in the United States in 
2010, with the building and construction industry accounting for more than one-third of that 
total [American Chemistry Council, 2011].
The objective of this study was to use data from state-based WRA surveillance and 
Occupational Safety and Health Administration (OSHA) Integrated Management 
Information System (IMIS) isocyanate air sampling to identify industries in the four states 
where workers have become ill, or may be at risk of exposure to potentially hazardous levels 
of isocyanates. In California, Massachusetts, and New Jersey, the WRA surveillance 
systems and the IMIS data system are independent sources of information about isocyanates 
in the workplace. In Michigan, data from the WRA surveillance system and the IMIS data 
system can be linked, as many isocyanate inspections were based on referrals from the WRA 
surveillance program.
MATERIALS AND METHODS
State-Based WRA Surveillance Data
From 1993 through 2008, the National Institute for Occupational Safety and Health 
(NIOSH), Centers for Disease Control and Prevention funded surveillance of WRA in four 
states: California, Massachusetts, Michigan, and New Jersey. The states used multiple data 
sources to identify persons with WRA and compile demographic, industry, and exposure 
information. The methods for WRA surveillance case identification, confirmation, and 
classification have been previously described [Rosenman et al., 1997; Henneberger et al., 
1999; Jajosky et al., 1999; Rosenman et al., 2003 Pechter et al., 2005; Mazurek et al., 2008]. 
The surveillance case definition for WRA required a health-care professional’s diagnosis 
consistent with asthma and an association between symptoms of asthma and work [Jajosky 
et al., 1999]. Each case was classified into one of the following categories: work-aggravated 
asthma (WAA) defined as pre-existing asthma exacerbated by workplace exposures, or new-
onset asthma (NOA) defined as asthma in a person with no history of asthma or preexisting 
asthma that has been asymptomatic for at least two years prior to the onset of work-related 
symptoms. NOA included reactive airways dysfunction syndrome (RADS), a non-
immunologic asthma lasting at least three months typically caused by a single exposure to 
high levels of an irritating vapor, gas, fume, or smoke; and occupational asthma (OA), 
which developed after a period of asymptomatic exposure to an etiologic agent. Surveillance 
data also included WRA cases for which there was insufficient information to classify into 
the above categories.
Industry was coded according to the 1987 Standard Industrial Classification (SIC). Reported 
exposures were coded according to the Association of Occupational and Environmental 
Clinics (AOEC) Exposure Codes. The AOEC exposure codes 221.00–221.06 were used to 
identify cases of WRA associated with isocyanate exposure [AOEC, 2014]. We analyzed all 
WRA cases for the period January 1, 1993 through December 31, 2008 for which an 
isocyanate was reported as at least one of the three possible exposures associated with the 
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WRA. We analyzed the frequency and proportion of isocyanate-induced WRA cases by 
industry, age, gender, race and ethnicity using SAS® version 9.2 (SAS Institute, Cary, NC). 
Use of workers’ compensation (WC) by cases, as reported on interview or medical record 
review, was also examined.
OSHA IMIS Sampling Data
The Occupational Safety and Health Administration (OSHA) launched the Integrated 
Management Information System (IMIS) database in 1984. The IMIS database contained 
information on inspection history for inspected establishments, any citations issued, 
standards cited, complaints investigated, employer-requested consultation evaluations, and 
air sampling results [USDOL, 2012]. Air sampling for isocyanates was conducted using 
standard protocols, as specified in OSHA’s Sampling and Analytical Methods [OSHA, 
2015].
Through an agreement with OSHA, access was granted to use the IMIS database of air-
sampling results for 1993 through 2008 from the four states. Methods used in analyzing the 
IMIS data were based on Henn et al. [2011]. Nationwide air sampling data were extracted 
for the following isocyanates: MDI, TDI, HDI and its biuret, isophorone diisocyanate 
(IPDI), 1,5 naphthalene diisocyanate (NDI), and methylene bis (4-cyclohexylisocyanate). 
There were 9,379 air samples collected for all isocyanates in the United States over the 16-
year period, of which 1,908 were in the four states under study. These included results 
collected by federal OSHA in Massachusetts and New Jersey, California OSHA (Cal/
OSHA) and Michigan OSHA (MIOSHA) to evaluate exposures to isocyanates as part of 
either enforcement or employer consultation worksite visits. Sampling results were excluded 
if they were coded as not detected, not found or not valid, where the exposure level was 
zero, or where units for the sample were missing. The remaining samples were considered 
“detectable” and retained for analysis. Detectable samples were used as a proxy for worker 
exposure. Industry information in the IMIS data was coded according to 1987 SIC. Data 
were analyzed by state and by SIC to identify industries with potential worker exposure to 
isocyanates.
Detectable samples were compared to the relevant Permissible Exposure Limits (PELs) as 
promulgated by OSHA, Cal/OSHA, and MIOSHA. Sample results that were greater than the 
respective federal or state standard were considered overexposures (Supplemental Material: 
Table I: A summary of the enforceable PELs and guidelines set by NIOSH, the 
Recommended Exposure Limits [RELs], and the American Conference of Governmental 
Industrial Hygienists [ACGIH] Threshold Limit Values [TLVs]). It is important to note that 
federal OSHA has PELs only for MDI and 2,4-TDI and that these are ceiling exposure 
limits, not 8 hr time-weighted averages (TWAs). NIOSH and ACGIH recommended 
guidelines and state regulations also include 8 hr TWAs and Short Term Exposure Limits 
(STELs), as well as “skin” designations for some of the isocyanates.
Protection of Human Subjects
As part of requirements for the NIOSH funded grants, the following Institutional Review 
Boards reviewed and approved the respective asthma projects including approval of 
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obtaining informed verbal consent from participating subjects: State of California 
Committee for the Protection of Human Subjects; Massachusetts Department of Public 
Health Institutional Review Board; Michigan State University Human Subjects Review 
Board; and New Jersey Department of Health’s Institutional Review Board.
RESULTS
State-Based WRA Surveillance Data
A total of 368 cases of WRA associated with isocyanate exposure were identified by the 
four states. Examples of case reports from each state are included (Supplemental Material: 
Case Reports). Demographics, including age, gender, race, and ethnicity are presented in 
Table I. Cases ranged in age from 19 to 78 years (mean: 42.5 years). Most cases were male 
(n = 225, 61%), white (n = 280, 76%), and non-Hispanic/Latino (n = 295, 80%). Michigan 
had the greatest total number of cases (n = 268).
Of the 368 WRA cases, 347 (94%) were classified as NOA, 14 (4%) were classified as 
WAA, and for seven (2%) there was insufficient information to classify. The NOA cases 
included 18 (5% of 368) cases of RADS and 329 (89% of 368) cases of OA (Table II).
Among the 312 cases for which WC filing status was known, a total of 173 (56%) reported 
filing a claim; California 63%, Massachusetts 74%, Michigan 52%, and New Jersey 57%. 
Of the 173 who had filed a claim, 171 (99%) had a known outcome; 62 (36%) reported 
having received WC benefits, 86 (50%) claims were pending at the time of the interview, 
and 23 (13%) individuals were denied WC benefits.
The types of isocyanate exposures reported by isocyanate-induced WRA cases by state are 
listed in Table III. Half (n = 195, 50%) of the reported exposures were coded for a specific 
isocyanate, and the most common isocyanates reported were MDI (n = 88, 24%) and TDI (n 
= 86, 23%).
Isocyanates are frequently used with other chemicals. We examined additional non-
isocyanate chemical exposures for those persons identified with isocyanate-induced WRA. 
In total, 101 non-isocyanate exposures were identified. The most frequent agent categories 
were: solvents (n = 24), glues/resins (n = 14), nonmetal dusts (n = 11), paints (n = metals/
metal dusts (n = 7), 10), and cleaning chemicals (n = 6).
OSHA Sampling Data
Of the 1,908 air samples for isocyanates collected from California, Massachusetts, 
Michigan, and New Jersey from 1993 through 2008, 678 (36%) had detectable levels. The 
detectable samples were evenly divided between consultation site visit samples (n = 343, 
51%) and enforcement site visit samples (n = 335, 49%). Because industry sectors may have 
contained data from only one worksite, we examined the distribution of detectable samples 
by worksite using enforcement data (information on worksite was not sufficient in 
consultation data). The number of detectable samples per worksite varied. We found, using 
enforcement data, that the distribution of the number of detectable samples per worksite was 
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similar to the distribution of detectable samples by industry sector (data not shown). 
Notably, only 80 (12%) of the sample results exceeded their respective PELs.
Industry Findings
Data from both sources were analyzed to detect similarities and differences by industry. The 
industries with the most isocyanate-induced WRA cases were Transportation Equipment 
Manufacturing (SIC 37, n = 155); Rubber and Miscellaneous Plastics Manufacturing (SIC 
30, n = 27); and Chemicals and Allied Products Manufacturing (SIC 28, n = 26). The 
industries with the largest numbers of detectable air samples were Auto Repair Services (SIC 
75, n = 155 with 40 samples greater than the respective PEL [40>PEL]), Rubber and 
Miscellaneous Plastics Manufacturing (SIC 30, n = 100; 8>PEL), and Transportation 
Equipment Manufacturing (SIC 37, n = 80; 15>PEL). Overall, state-based WRA 
surveillance identified eight industries where 27 cases of isocyanate-induced WRA worked 
and no detectable samples were reported in the OSHA IMIS database. In turn, IMIS 
identified eight industries in which there were no cases of WRA (Table IV).
DISCUSSION
Identification of Industries Associated With Isocyanates in the Two Systems
Potentially hazardous exposures to isocyanates, as indicated by the presence of a case of 
isocyanate-induced WRA, an air sample with detectable level of isocyanate, or both, 
continue in a wide variety of industries. In this report, many of the industries identified using 
both data sources such as Transportation Equipment Manufacturing, Auto Repair Services 
and Rubber and Miscellaneous Plastics Manufacturing are well recognized as industries that 
use isocyanates and where workers develop isocyanate-induced WRA [Bonauto et al., 2005; 
OSHA, 2013a].
We identified industries where the potential for isocyanate exposure is not widely 
recognized. For example, there were four cases of WRA in the Textile Mill Products (SIC 
22) industry where isocyanates were used in the lamination process (Supplemental Material: 
Case Report #1) and three cases in the Stone, Clay, Glass, and Concrete Products (SIC 32) 
industry where isocyanates were used in coatings. We also identified 12 cases of isocyanate-
induced WRA in Sporting and Athletic Goods Manufacturing (SIC 39) where isocyanates 
were used in the manufacturing of products such as golf balls (Supplemental Material: Case 
Report #2). Despite the finding of WRA cases, there were limited numbers of detectable 
isocyanate samples by OSHA in each of these three SIC codes (40 samples in SIC 22, 10 in 
SIC 32, and 2 in SIC 39). Several other industries less commonly recognized as posing risks 
of exposure to isocyanates for workers were found through the presence of WRA cases 
alone. Isocyanate-induced WRA cases occurred in Educational Services (SIC 82) where 
cases were exposed during school building renovations, Public Administration (SIC 92, 97) 
where, for example, a police officer developed WRA after responding to an isocyanate spill, 
and Food and Kindred Products (SIC 20) where an individual had a secondary exposure to 
an isocyanate product used in a floor coating in a commercial bakery. To our knowledge, 
isocyanate-induced WRA cases have not been previously documented in these industries.
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The exposures in these industries (SIC 20, 82, 92, 97) are secondary to other activities, and 
are different from the well-documented process exposures in the Transportation Equipment 
Manufacturing and Auto Repair Services industries. For these types of secondary exposures, 
recognition of isocyanate use, risk anticipation, and exposure avoidance are key to WRA 
prevention. A number of cases arose from construction and repair activities, in which 
isocyanates were ingredients in materials used as sealants, roofing or floor and wall 
coatings. Such secondary exposures may be prevented by careful review of materials to be 
used, communication about ingredients and necessary cautions, including avoiding 
bystander exposure and observing reentry protocols.
In addition, there were seven cases of WRA in the Health Services (SIC 80) industry where 
exposure to MDI-containing synthetic orthopedic casting and immobilization cradles have 
been previously documented [MDPH, 1999; Donnelly et al., 2004; Suojalehto et al., 2011].
It is not surprising that there were cases of WRA in industries with no detectable samples. 
OSHA does not investigate all isocyanate-using workplaces, nor does it conduct air 
sampling on every isocyanate-related investigation. More importantly, isocyanates may not 
be airborne at consistent levels during all work hours. Isocyanate use may be intermittent 
(e.g., spill cleanup), product-specific, related to infrequent maintenance, or exposure may be 
indirect [Petsonk et al., 2000; Reeb-Whitaker et al., 2013]. In addition, accurate air sampling 
for isocyanates is difficult, imprecise, and dependent on whether isocyanates are in gas or 
aerosol form, the size of the particles, the extraction and laboratory analysis methods used 
and the effectiveness in capturing monomers and polymers [Streicher et al., 2000; Bello et 
al., 2004; Lesage et al., 2007; Henneken et al., 2007; Booth et al., 2009; Thomasen et al., 
2011; Reeb-Whitaker et al., 2012; Schaeffer et al., 2013; Lockey et al., 2015]. For example, 
Thomasen et al. [2011] found differential capture of monomer and polymer of HDI and 
variation depending on whether autobody paint was fast-drying or slow-drying; Lesage et al. 
[2007] found that filter sampling method results were up to 40% lower than results from 
impinger methods. OSHA has since altered their filter handling methods to improve 
accuracy by requiring field extraction [OSHA, 2013a]. In addition, the primary route of 
exposure that caused respiratory sensitization may have been dermal [Bello et al., 2007] and 
some workers may develop WRA from exposure to airborne isocyanates at levels below the 
limit of detection [Banks et al., 1989].
We did, however, identify additional industries with detectable levels of isocyanates where 
workers may be at risk, but no isocyanate-induced WRA cases were ascertained, for 
example: Paper and Allied Products Manufacturing (SIC 26), Services Not Elsewhere 
Classified (SIC 89), Furniture and Fixtures Manufacturing (SIC 25), and Building 
Materials, Hardware, Garden Supply and Mobile Home Dealers (SIC 52). Not all cases of 
WRA are identified and reported (see Limitations of Data Systems).
Michigan was the only state in which OSHA IMIS data could be linked with state-based 
WRA surveillance data. Of the 268 isocyanate-induced WRA cases ascertained in Michigan, 
194 (72%) were associated with 106 MIOSHA inspections. Although MIOSHA sampling 
was conducted in 84 (79%) of the 106 inspections, none of the air samples collected were 
above the PEL for the respective isocyanate (data not shown). WRA developed despite 
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isocyanate air concentrations found to be less than the PEL subsequent to diagnosis of 
WRA, as described in Case Report # 3 (Supplemental Material). While it is possible that 
some workers with WRA had previously experienced higher levels of exposure, these 
findings suggest that compliance with MIOSHA PELs was not sufficient to prevent WRA.
Workers’ Compensation
The finding that only 56% of individuals with isocyanate-induced WRA had filed for WC 
benefits to which they may be entitled is consistent with prior reports that individuals with 
WRA may never apply for WC [Azaroff et al., 2002; Luckhaupt and Calvert, 2010]. It is not 
known why individuals with isocyanate-induced WRA did not file WC claims, which could 
have covered the medical treatment for asthma, including asthma medication, job retraining, 
and provided lost income coverage [Biddle et al., 1998]. The denial of benefits for 13% of 
claims for this well-recognized hazard is of concern. A better understanding of methods to 
overcome barriers to filing WC claims and receiving benefits by both workers and 
healthcare providers is needed [Azaroff et al., 2002].
Limitations of Data Systems
Limitations of state-based WRA surveillance have been discussed previously [Rosenman et 
al., 1997; Henneberger et al., 1999; Jajosky et al., 1999; Rosenman et al., 2003; Pechter et 
al., 2005; Mazurek et al., 2008]. The number of WRA cases ascertained by state-based 
surveillance underestimates the true number of cases, and cases ascertained may not be 
representative of all WRA in the underlying population [Jajosky et al., 1999]. In a capture-
recapture analysis conducted in Michigan, the surveillance system was shown to have 
missed 53–87% of WRA cases in the state [Henneberger et al., 1999]. This was largely due 
to underreporting, despite the fact that healthcare providers were legally mandated to report 
WRA. Sama et al. [2003] found that only 7% of adult New England Health Maintenance 
Organization (HMO) members with new-onset asthma had medical record documentation 
that they were asked about workplace exposures by their health care providers. Mazurek and 
Storey [2012] found that only 13.5% of adults with asthma had ever discussed with their 
healthcare provider whether their asthma could be work related. Diagnosis of WRA may be 
challenging due to difficulty in linking workplace exposures with disease, especially in cases 
of delayed symptoms and delayed onset of disease [Tarlo et al., 2008].
The work-related asthma cases in this study are based on a physicians’ diagnosis of asthma, 
clinical and occupational information, including exposures, onset, timing, severity related to 
work [Jajosky et al., 1999; Tarlo et al., 2008]. Less than 10% of cases in the WRA 
surveillance system have peak flow or spirometry performed in relationship to work, and 
none had specific antigen challenge testing. This reflects the standard of medical care for 
diagnosing WRA in the United States [Tarlo et al., 2008]. The lack of breathing tests 
performed in relationship to work and specific antigen challenge testing may lead to over 
diagnosis of WRA. In addition, cases may have been attributed to isocyanate exposures 
when other exposures were the etiologic agents. This may also be true for RADS, where 
although individual case reports of RADS after isocyanate exposure have been reported 
[Luo et al., 1990; Shakeri et al., 2008; Baur et al., 2012], it is possible that some of the 
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RADS cases we have included may have been from spills/leaks of other chemicals present 
with the isocyanates.
The IMIS data are a valuable indicator of potential worker exposure in various workplaces, 
but this database was not designed as an exposure surveillance system. The presence of 
detectable air samples of isocyanates in the OSHA IMIS dataset was selected as the most 
conservative indicator of potential airborne exposure to isocyanates, with possible risk of 
development of disease. Workers might also be at risk from dermal contact, intermittent 
exposures not captured in the sampling, and exposure to very low concentrations, below the 
limit of detection. However, the detectable levels recorded are tangible evidence that 
isocyanates were in the workplace air at the time of sampling.
The OSHA IMIS data may not be representative of all workplace isocyanate exposures; they 
reflect only the exposures in worksites either inspected for compliance, or visited in 
response to employer requests. In the four states, over the 16-year period, 356 worksites had 
federal OSHA, Cal/OSHA or MIOSHA enforcement visits that included air sampling for 
isocyanates. A report from Michigan showed that of the 103 companies known to use large 
quantities of isocyanates in that state, 32 (31%) had a MIOSHA enforcement inspection, and 
in 21 of the 32 the inspector proceeded to conduct air sampling [MSUDOM, 2013]. It is not 
possible to determine the percentage of all companies using isocyanates that MIOSHA 
investigated, as no comprehensive list of companies that use isocyanates exists in Michigan 
or any other state.
The data in IMIS were incomplete and had errors. There is likely differential underreporting 
of non-detectable samples [Lavoue et al., 2013a] and likely underreporting of detectable 
samples for isocyanates without PELs, adding to barriers to retrieving complete data 
[Lavoue et al., 2013b; Williams 2014]. IMIS nondetectable results could not be used to 
estimate isocyanate air concentrations. Without documented data about the duration of 
sampling or the limit of detection (LOD), a midpoint between zero and the LOD could not 
be used to calculate an estimated concentration for non-detectable results. The absence of 
detectable levels is not equivalent to no exposure. Skin exposures were not considered in 
these data even though skin absorption may be a significant exposure source [Liu et al., 
2009; Redlich, 2010]. Moreover, no information was available to assess the validity of the 
OSHA IMIS data.
Prevention
Strategies to replace isocyanates with safer products and to prevent WRA are important in 
all industries where isocyanates are used. Since reducing exposure to isocyanates helps 
prevent the development of new cases and exacerbations of WRA in existing cases 
[Walworth and Virchow, 1959], effective use of engineering controls to minimize exposure 
to isocyanates is necessary. Ventilation systems (e.g., spray booths) and personal protective 
equipment (PPE) to prevent inhalation and dermal contact should be used together 
[Heederik et al., 2012]. Poor exposure controls and poorly managed PPE use can result in 
the development of WRA (Supplemental Material: Case Report #4). For example, 
Washington’s Safety and Health Assessment and Research for Prevention (SHARP) 
program determined that substitution or respiratory protection was needed for paint spray 
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applications on large objects that cannot be accommodated in a spray booth (e.g., aircraft 
parts, boats, fire engines) [Reeb-Whitaker, 2013].
Respiratory protection programs must include a comprehensive written program and 
medical evaluation for fitness to wear respirators, as well as proper selection, training, use, 
and fit testing of respirators [OSHA, 2014a]. In one isocyanate-induced WRA case where 
the worker subsequently died, the worker was wearing a positive-pressure supplied-air 
respirator while applying a spray-on truck bed liner. However, the supply line was too long 
for the pump, and the worker had not been fit-tested, trained on the hazards of isocyanates, 
nor provided a medical evaluation or periodic screening [Michigan FACE, 2003; Chester et 
al., 2005].
Periodic medical screening of all isocyanate exposed workers with removal of those who 
develop isocyanate-induced WRA, especially in the early years of work, is vital to reduce 
morbidity [Chan-Yeung, 1986; Wild et al., 2005; Labrecque et al., 2011; Tarlo and Lemiere, 
2014]. Preplacement screening has not been shown to be effective in identifying individuals 
who should be excluded from being hired [Tarlo et al., 2008; Wilken et al., 2012]. An 
example of the benefits of early removal from exposure can be found in Case Report #3 
(Supplemental Material: Case Reports), where a worker with isocyanate-induced WRA 
became asymptomatic after being removed from the workplace.
A decline in isocyanate-induced asthma cases has been described in the UK and Canada 
[Ribeiro 2014; Walters et al., 2015]. The number of isocyanate-induced WRA cases has 
declined from 1993 to 2008 in all four states (data not shown). Postulated reasons for the 
decline are many, including health care provider reporter fatigue, absence of medical 
surveillance of exposed workers, improved controls and the substitute of less volatile 
isocyanates such as prepolymers [Lockey et al 2015; Walters et al., 2015]. Despite the 
apparent decline, measures should be implemented to further reduce this preventable 
disease.
Adequacy of Existing PELs
Currently, PELs for many isocyanates, including new variations of isocyanates, do not exist. 
Moreover, OSHA, MIOSHA, and CalOSHA did not issue many citations for exposures over 
the existing PELs. However, companies inspected for isocyanate issues were cited for 
failure to do a hazard assessment, provide hazard communication and use PPE, indicating 
lapses in worker protection. The PELs in place do not protect those who are already 
sensitized, since exposures below the PELs can trigger symptoms [Lemiere et al., 2002]. 
Additionally, exposures below the PELs may induce sensitization, with dermal contact as a 
contributory element. [Reilly et al., 2001; Matheson et.al, 2005]. Significantly, in its 1989 
proposed standard (Health Effects Discussion and Determination of Final PEL), OSHA cited 
multiple studies stating that workers can develop sensitization reactions to TDI at exposure 
levels below the 0.02 ppm level [OSHA, 1989]. Also, the current sampling methods may 
underestimate exposures for many reasons, as described above. Therefore, PELs should be 
updated where they exist and a comprehensive standard should be developed for all 
isocyanates that addresses task-specific guidance, spill clean-up procedures, skin and 
respiratory protection, and targeted medical surveillance and medical removal protection 
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[Tarlo et al., 2002; Pronk et al., 2006; Booth et al., 2009; Cocker 2011; Baur et al., 2012; 
Wisnewski et al., 2012; Pearson et al., 2013; Williams, 2014].
In June 2013, OSHA developed a National Emphasis Program (NEP) to reduce or eliminate 
the incidence of adverse health effects, including asthma, associated with workplace 
exposure to isocyanates [OSHA, 2013a]. The OSHA NEP on isocyanates includes field 
enforcement guidance, and suggested industries where isocyanate exposures were known or 
likely to occur and encouraged communication with state-based WRA surveillance 
programs to identify industries where isocyanate induced WRA had occurred. OSHA 
developed a fact sheet for workers and clinicians to use to assist in early health assessments 
of WRA [OSHA, 2014b]. In addition, OSHA recognized that many of the adopted PELs are 
inadequate, and developed annotated PEL tables to aid employers in evaluating the best way 
to protect workers [OSHA, 2013b].
CONCLUSION
Detectable isocyanate exposures and isocyanate-induced WRA cases were found across 
many industries. Examining sentinel case data from state surveillance systems and exposure 
data collected by OSHA gives a more comprehensive picture of the widespread use and 
health consequences of isocyanates than either system alone.
Employers should be vigilant about reducing or eliminating worker exposure to isocyanates. 
Substitution, engineering controls, administrative changes, personal protective equipment, 
hazard awareness and education, medical monitoring, and best practices in product usage are 
recommended. OSHA’s current NEP for isocyanates is an important first step in both 
increasing awareness of the ongoing hazards of isocyanates and identifying solutions to 
reduce the risk from their use. Additional consideration should be given to the development 
of a comprehensive standard for isocyanates that also promotes education, medical 
monitoring, and worksite evaluation and control. Finally, cases of WRA identified by health 
care providers should trigger evaluation of the workplace by health and safety professionals 
to protect coworkers, provide insight about exposures, and promote the development of 
asthma prevention strategies.
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TABLE II
Classification of Isocyanate Work-Related Asthma Cases–California, Massachusetts, Michigan, and New 
Jersey, 1993–2008
Classification of work-related asthma
Isocyanate Cases Total WRA Cases
Number % Number %
Work-aggravated asthma 14 4 1,654 20
New onset asthma 347 94 4,230 51
 Reactive airways dysfunction syndrome 18 5 609 7
 Occupational asthma 329 89 3,621 44
Insufficient data to classify 7 2 2,355 29
Total 368 100 8,239 100
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TABLE IV
Number and Percentage of Isocyanate Work-related Asthma, OSHA Air Samples With Detectable 
Isocyanates, and Detectable Samples Over the PEL, by Industry–California, Massachusetts, Michigan, and 
New Jersey,1993–2008
Industry (SIC Code)






samples over PEL 
(/detectables ×100)
Manufacturing (20, 22–26, 28, 30, 32–39) 289 79 443 35 (8%)
 Transportation equipment (37) 155 42 80 15 (19%)
 Rubber and miscellaneous plastics (30) 27 7 100 8 (8%)
 Chemicals and allied products (28) 26 7 21 1 (5%)
 Industrial and commercial machinery (35) 24 7 47 4 (9%)
 Miscellaneous manufacturing/sporting and athletic goods (39) 15 4 2 –
 Primary metal industries (33) 13 4 22 1 (5%)
 Fabricated metal products, except machinery, and transportation (34) 6 2 39 0
 Electronic and other electrical equipment and components, except 
computer equipment (36)
6 2 16 2 (12%)
 Lumber and wood products (except furniture) (24) 5 1 6 –
 Textile mill products (22) 4 1 40 1 (2%)
 Measuring, analyzing, and controlling instruments (38) 3 1 26 2 (8%)
 Stone, clay, glass, and concrete products (32) 3 1 10 1 (10%)
 Food & kindred products (20) 1 – – –
 Apparel and other finished products made from fabrics and similar 
materials (23)
1 – 5 –
 Paper and allied products (26) – – 18 –
 Furniture and fixtures (25) – – 9 –
Services (70, 75, 76, 78, 80, 82, 87, 89) 48 13 174 41 (24%)
 Auto repair services (75) 23 6 155 40 (26%)
 Health services (80) 7 2 – –
 Educational services (82) 6 2 – –
 Engineering, accounting, research, management, and related services 
(87)
5 1 2 –
 Business services (73) 4 1 2 –
 Miscellaneous repair services (76) 2 1 2 1 (50%)
 Hotels, rooming houses, camps, and other lodging places (70) 1 – – –
 Services, not elsewhere classified (89) – – 12 –
 Motion pictures (78) – – 1 –
Construction (15–17) 8 2 37 2 (5%)
 Special trade contractors: masonry, stonework, plaster (17) 7 2 23 –
 Heavy construction, except building (16) 1 – 13 –
 Building construction–general contractors and operative builders 
(15)
– – 1 –
Transportation, communication, electricity, gas, sanitation services (41, 
42, 44, 45, 47, 49)
6 2 15 –
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Industry (SIC Code)






samples over PEL 
(/detectables ×100)
 Air transport (45) 2 1 14 –
 Motor freight transportation and warehousing (42) 2 1 – –
 Local and suburban transit and interurban highway passenger 
transportation (41)
1 – 1 –
 Electric, gas, and sanitary services (49) 1 – – –
 Water transport (44) – – 3 –
 Transportation services (47) – – 1 –
Wholesale trade (50, 51) 6 2 3 –
 Wholesale trade–nondurable goods (51) 3 1 2 –
 Wholesale trade–durable goods (50) 3 1 1 –
Public administration (92, 97) 5 1 – –
 Justice, public order, and safety (92) 4 1 – –
 National security and international affairs (97) 1 – – –
Retail trade (52, 55) 4 1 6 2 (33%)
 Automotive dealers and gas service stations (55) 4 1 – –
 Building materials, hardware, garden supply, and mobile home 
dealers (52)
– – 6 –
Totala 366 100 678 80 (12%)
OSHA, Occupational Safety and Health Administration; PEL, Permissible Exposure Limit; SIC, Standard Industrial Classification; WRA, Work-
related Asthma. –indicates no cases/samples ascertained.
a
Two cases were missing an industry code.
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